![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Research Papers
Cell Cycle Project, Glaxo Wellcome Research and Development, Research Triangle Park, North Carolina 27709, USA.
Abstract
MDM2 is a cellular protein that binds to and inactivates the p53 tumor suppressor protein. Although mdm2 has been shown to function as an oncogene in vitro, all studies to date have assessed MDM2 activities in the presence of p53, implicating p53 inactivation in MDM2-directed transformation. To determine the role of MDM2 in the cell cycle and in tumorigenesis and whether or not this role is dependent on p53, an MDM2 minigene was expressed during gestation and lactation in the mammary gland of both wild-type p53 (p53+/+) and p53 knockout (p53-/-) mice using the bovine beta-lactoglobulin promoter. In six different transgenic mouse lines, deregulated expression of MDM2 inhibited normal development and morphogenesis of the mammary gland, and caused cellular hypertrophy and nuclear abnormalities. These abnormalities included both multinucleated cells and enlarged cells with giant nuclei. Although there were fewer epithelial cells present in the transgenic mammary gland, no apoptosis was observed. Instead, BrdU incorporation and PCNA staining showed that 12%-27% of the transgenic mammary epithelial cells were in S phase at a time when normal cells were terminally differentiated. Analysis of DNA content showed that 30%-45% of the cells were polyploid, with DNA contents up to 16N, indicating that overexpression of MDM2 caused mammary epithelial cells to undergo multiple rounds of S phase without cell division. This phenotype was similar in the p53+/+ and p53-/- background, demonstrating a role for MDM2 in the regulation of DNA synthesis that is independent of the ability of MDM2 to inhibit p53 activity. Additionally, multiple lines of BLGMDM2 transgenic mice developed mammary tumors, confirming that overproduction of MDM2 contributes to tumorigenesis in epithelial cells in vivo.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Bouska, T. Lushnikova, S. Plaza, and C. M. Eischen Mdm2 Promotes Genetic Instability and Transformation Independent of p53 Mol. Cell. Biol., August 1, 2008; 28(15): 4862 - 4874. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wang, Z. Zhang, H. Zhu, G. Fu, S. Wang, D. Wu, J. Zhou, Q. Wei, and Z. Zhang A Novel Functional Polymorphism C1797G in the MDM2 Promoter Is Associated with Risk of Bladder Cancer in a Chinese Population Clin. Cancer Res., June 1, 2008; 14(11): 3633 - 3640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Maguire, P. C. Nield, T. Devling, R. E. Jenkins, B. K. Park, R. Polanski, N. Vlatkovic, and M. T. Boyd MDM2 Regulates Dihydrofolate Reductase Activity through Monoubiquitination Cancer Res., May 1, 2008; 68(9): 3232 - 3242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Forslund, Z. Zeng, L.-X. Qin, S. Rosenberg, M. Ndubuisi, H. Pincas, W. Gerald, D. A. Notterman, F. Barany, and P. B. Paty MDM2 Gene Amplification Is Correlated to Tumor Progression but not to the Presence of SNP309 or TP53 Mutational Status in Primary Colorectal Cancers Mol. Cancer Res., February 1, 2008; 6(2): 205 - 211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Kannemeier, R. Liao, and P. Sun The RING Finger Domain of MDM2 Is Essential for MDM2-mediated TGF-beta Resistance Mol. Biol. Cell, June 1, 2007; 18(6): 2367 - 2377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. V. Poyurovsky and C. Prives Unleashing the power of p53: lessons from mice and men Genes & Dev., January 15, 2006; 20(2): 125 - 131. [Full Text] [PDF]
|
|
|
|
|
|
A. Tanaka, S. Muto, M. Konno, A. Itai, and H. Matsuda A New I{kappa}B Kinase {beta} Inhibitor Prevents Human Breast Cancer Progression through Negative Regulation of Cell Cycle Transition Cancer Res., January 1, 2006; 66(1): 419 - 426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Giglio, F. Mancini, F. Gentiletti, G. Sparaco, L. Felicioni, F. Barassi, C. Martella, A. Prodosmo, S. Iacovelli, F. Buttitta, et al. Identification of an Aberrantly Spliced Form of HDMX in Human Tumors: A New Mechanism for HDM2 Stabilization Cancer Res., November 1, 2005; 65(21): 9687 - 9694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Alt, A. Bouska, M. R. Fernandez, R. L. Cerny, H. Xiao, and C. M. Eischen Mdm2 Binds to Nbs1 at Sites of DNA Damage and Regulates Double Strand Break Repair J. Biol. Chem., May 13, 2005; 280(19): 18771 - 18781. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Zhou, R. Frum, S. Deb, and S. P. Deb The Growth Arrest Function of the Human Oncoprotein Mouse Double Minute-2 Is Disabled by Downstream Mutation in Cancer Cells Cancer Res., March 1, 2005; 65(5): 1839 - 1848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Sdek, H. Ying, H. Zheng, A. Margulis, X. Tang, K. Tian, and Z.-X. J. Xiao The Central Acidic Domain of MDM2 Is Critical in Inhibition of Retinoblastoma-mediated Suppression of E2F and Cell Growth J. Biol. Chem., December 17, 2004; 279(51): 53317 - 53322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Zhang, H. Wang, G. Prasad, M. Li, D. Yu, J. A. Bonner, S. Agrawal, and R. Zhang Radiosensitization by Antisense Anti-MDM2 Mixed-Backbone Oligonucleotide in in Vitro and in Vivo Human Cancer Models Clin. Cancer Res., February 15, 2004; 10(4): 1263 - 1273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A. Steinman, E. Burstein, C. Lengner, J. Gosselin, G. Pihan, C. S. Duckett, and S. N. Jones An Alternative Splice Form of Mdm2 Induces p53-independent Cell Growth and Tumorigenesis J. Biol. Chem., February 6, 2004; 279(6): 4877 - 4886. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Green, K. Desai, Y. Ye, C. Kavanaugh, A. Calvo, and J.-I. Huh Genomic Approaches to Understanding Mammary Tumor Progression in Transgenic Mice and Responses to Therapy Clin. Cancer Res., January 1, 2004; 10(1): 385S - 390S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Zhu, L. Wu, and C. G. Maki MDM2 and Promyelocytic Leukemia Antagonize Each Other through Their Direct Interaction with p53 J. Biol. Chem., December 5, 2003; 278(49): 49286 - 49292. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. WANG, P. OLIVER, Z. ZHANG, S. AGRAWAL, and R. ZHANG Chemosensitization and Radiosensitization of Human Cancer by Antisense Anti-MDM2 Oligonucleotides: In Vitro and in Vivo Activities and Mechanisms Ann. N.Y. Acad. Sci., December 1, 2003; 1002(1): 217 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Deb Cell Cycle Regulatory Functions of the Human Oncoprotein MDM2 Mol. Cancer Res., December 1, 2003; 1(14): 1009 - 1016. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Ganguli and B. Wasylyk p53-Independent Functions of MDM2 Mol. Cancer Res., December 1, 2003; 1(14): 1027 - 1035. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Phelps, M. Darley, J. N. Primrose, and J. P. Blaydes p53-independent Activation of the hdm2-P2 Promoter through Multiple Transcription Factor Response Elements Results in Elevated hdm2 Expression in Estrogen Receptor {alpha}-positive Breast Cancer Cells Cancer Res., May 15, 2003; 63(10): 2616 - 2623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.-A. Wang, R. K. Vadlamudi, R. Bagheri-Yarmand, I. Beuvink, N. E. Hynes, and R. Kumar Essential functions of p21-activated kinase 1 in morphogenesis and differentiation of mammary glands J. Cell Biol., May 12, 2003; 161(3): 583 - 592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Bagheri-Yarmand, R. K. Vadlamudi, and R. Kumar Activating Transcription Factor 4 Overexpression Inhibits Proliferation and Differentiation of Mammary Epithelium Resulting in Impaired Lactation and Accelerated Involution J. Biol. Chem., May 2, 2003; 278(19): 17421 - 17429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Asahara, Y. Li, J. Fuss, D. S. Haines, N. Vlatkovic, M. T. Boyd, and S. Linn Stimulation of human DNA polymerase {epsilon} by MDM2 Nucleic Acids Res., May 1, 2003; 31(9): 2451 - 2459. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bartl, J. Ban, H. Weninger, G. Jug, and H. Kovar A small nuclear RNA, hdm365, is the major processing product of the human mdm2 gene Nucleic Acids Res., February 15, 2003; 31(4): 1136 - 1147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Gu, H. W. Findley, and M. Zhou MDM2 induces NF-kappa B/p65 expression transcriptionally through Sp1-binding sites: a novel, p53-independent role of MDM2 in doxorubicin resistance in acute lymphoblastic leukemia Blood, May 1, 2002; 99(9): 3367 - 3375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Eischen, M. F. Roussel, S. J. Korsmeyer, and J. L. Cleveland Bax Loss Impairs Myc-Induced Apoptosis and Circumvents the Selection of p53 Mutations during Myc-Mediated Lymphomagenesis Mol. Cell. Biol., November 15, 2001; 21(22): 7653 - 7662. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wang, L. Nan, D. Yu, S. Agrawal, and R. Zhang Antisense Anti-MDM2 Oligonucleotides As a Novel Therapeutic Approach to Human Breast Cancer: In Vitro and in Vivo Activities and Mechanisms Clin. Cancer Res., November 1, 2001; 7(11): 3613 - 3624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Fata, V. Chaudhary, and R. Khokha Cellular Turnover in the Mammary Gland Is Correlated with Systemic Levels of Progesterone and Not 17{beta}-Estradiol During the Estrous Cycle Biol Reprod, September 1, 2001; 65(3): 680 - 688. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Shin, N. Charuruks, S. M. Lippman, J. J. Lee, J. Y. Ro, W. K. Hong, and W. N. Hittelman p53 Protein Accumulation and Genomic Instability in Head and Neck Multistep Tumorigenesis Cancer Epidemiol. Biomarkers Prev., June 1, 2001; 10(6): 603 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lukas, D.-Q. Gao, M. Keshmeshian, W.-H. Wen, D. Tsao-Wei, S. Rosenberg, and M. F. Press Alternative and Aberrant Messenger RNA Splicing of the mdm2 Oncogene in Invasive Breast Cancer Cancer Res., April 1, 2001; 61(7): 3212 - 3219. [Abstract] [Full Text]
|
|
|
|
|
|
C. Capoulade, L. M. Mir, K. Carlier, Y. Lecluse, C. Tetaud, Z. Mishal, and J. Wiels Apoptosis of tumoral and nontumoral lymphoid cells is induced by both mdm2 and p53 antisense oligodeoxynucleotides Blood, February 15, 2001; 97(4): 1043 - 1049. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. E. Blackshear Genetically Engineered Rodent Models of Mammary Gland Carcinogenesis: An Overview Toxicol Pathol, January 1, 2001; 29(1): 105 - 116. [Abstract] [PDF]
|
|
|
|
|
|
N. Vlatkovic, S. Guerrera, Y. Li, S. Linn, D. S. Haines, and M. T. Boyd MDM2 interacts with the C-terminus of the catalytic subunit of DNA polymerase {varepsilon} Nucleic Acids Res., September 15, 2000; 28(18): 3581 - 3586. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Franklin, V. L. Godfrey, D. A. O'Brien, C. Deng, and Y. Xiong Functional Collaboration between Different Cyclin-Dependent Kinase Inhibitors Suppresses Tumor Growth with Distinct Tissue Specificity Mol. Cell. Biol., August 15, 2000; 20(16): 6147 - 6158. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. R. Flores, B. L. Allen-Hoffmann, D. Lee, and P. F. Lambert The Human Papillomavirus Type 16 E7 Oncogene Is Required for the Productive Stage of the Viral Life Cycle J. Virol., July 15, 2000; 74(14): 6622 - 6631. [Abstract] [Full Text]
|
|
|
|
|
|
O. Loughran and N. B. La Thangue Apoptotic and Growth-Promoting Activity of E2F Modulated by MDM2 Mol. Cell. Biol., March 15, 2000; 20(6): 2186 - 2197. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Dilla, J. A. Velasco, D. L. Medina, J. F. Gonzalez-Palacios, and P. Santisteban The MDM2 Oncoprotein Promotes Apoptosis in p53-Deficient Human Medullary Thyroid Carcinoma Cells Endocrinology, January 1, 2000; 141(1): 420 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Oren Regulation of the p53 Tumor Suppressor Protein J. Biol. Chem., December 17, 1999; 274(51): 36031 - 36034. [Full Text] [PDF]
|
|
|
|
|
|
C. M. Eischen, J. D. Weber, M. F. Roussel, C. J. Sherr, and J. L. Cleveland Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis Genes & Dev., October 15, 1999; 13(20): 2658 - 2669. [Abstract] [Full Text]
|
|
|
|
|
|
S. E. Seavey, M. Holubar, L. J. Saucedo, and M. E. Perry The E7 Oncoprotein of Human Papillomavirus Type 16 Stabilizes p53 through a Mechanism Independent of p19ARF J. Virol., September 1, 1999; 73(9): 7590 - 7598. [Abstract] [Full Text]
|
|
|
|
|
|
H. L. Yang, Y. B. Dong, M. J. Elliott, T. J. Liu, C. Atienza Jr., A. Stilwell, and K. M. McMasters Adenovirus-mediated E2F-1 Gene Transfer Inhibits MDM2 Expression and Efficiently Induces Apoptosis in MDM2-overexpressing Tumor Cells Clin. Cancer Res., August 1, 1999; 5(8): 2242 - 2250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Pan and D. S. Haines The Pathway Regulating MDM2 Protein Degradation Can Be Altered in Human Leukemic Cells Cancer Res., May 1, 1999; 59(9): 2064 - 2067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Saucedo, C. D. Myers, and M. E. Perry Multiple Murine Double Minute Gene 2 (MDM2) Proteins Are Induced by Ultraviolet Light J. Biol. Chem., March 19, 1999; 274(12): 8161 - 8168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Reinke, D. M. Bortner, L. L. Amelse, K. Lundgren, M. P. Rosenberg, C. A. Finlay, and G. Lozano Overproduction of MDM2 in Vivo Disrupts S Phase Independent of E2F1 Cell Growth Differ., March 1, 1999; 10(3): 147 - 154. [Abstract] [Full Text]
|
|
|
|
|
|
M. H. G. Kubbutat, R. L. Ludwig, A. J. Levine, and K. H. Vousden Analysis of the Degradation Function of Mdm2 Cell Growth Differ., February 1, 1999; 10(2): 87 - 92. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. N. Jones, A. R. Hancock, H. Vogel, L. A. Donehower, and A. Bradley Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis PNAS, December 22, 1998; 95(26): 15608 - 15612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Pierce, I. B. Gimenez-Conti, R. Schneider-Broussard, L. A. Martinez, C. J. Conti, and D. G. Johnson Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53 PNAS, July 21, 1998; 95(15): 8858 - 8863. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Juven-Gershon, O. Shifman, T. Unger, A. Elkeles, Y. Haupt, and M. Oren The Mdm2 Oncoprotein Interacts with the Cell Fate Regulator Numb Mol. Cell. Biol., July 1, 1998; 18(7): 3974 - 3982. [Abstract] [Full Text]
|
|
|
|
|
|
J. T. Thomas and L. A. Laimins Human Papillomavirus Oncoproteins E6 and E7 Independently Abrogate the Mitotic Spindle Checkpoint J. Virol., February 1, 1998; 72(2): 1131 - 1137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Chen, S. Agrawal, W. Zhou, R. Zhang, and J. Chen Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage PNAS, January 6, 1998; 95(1): 195 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Peng, L. Chen, C. Li, W. Lu, S. Agrawal, and J. Chen Stabilization of the MDM2 Oncoprotein by Mutant p53 J. Biol. Chem., February 23, 2001; 276(9): 6874 - 6878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Boyd, N. Vlatkovic, and D. S. Haines A Novel Cellular Protein (MTBP) Binds to MDM2 and Induces a G1 Arrest That Is Suppressed by MDM2 J. Biol. Chem., October 6, 2000; 275(41): 31883 - 31890. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Zhang and C. Prives Cyclin A-CDK Phosphorylation Regulates MDM2 Protein Interactions J. Biol. Chem., August 3, 2001; 276(32): 29702 - 29710. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Elble and B. U. Pauli Tumor Suppression by a Proapoptotic Calcium-activated Chloride Channel in Mammary Epithelium J. Biol. Chem., October 26, 2001; 276(44): 40510 - 40517. [Abstract] [Full Text] [PDF]
|
|
